Analyst Viewpoint
The global veterinary molecular diagnostics market value is driven by growth in pet ownership and rise in prevalence of vector-borne diseases. Increase in the number of research and development activities, entry of new veterinary molecular diagnostic methods, and advancements in technology are driving the demand for veterinary molecular diagnostics.
Vendors are focusing on research and development activities and exploring the potential of collaborating with other players to strengthen their market position. Conventional microscopy results are often technique-sensitive and open to subjective interpretation.
Thus, vendors are developing innovative analyzers that eliminate manual workflow and image analysis steps while generating consistent, clinically actionable results for veterinarians.
Molecular diagnostics are laboratory methods used to examine the RNA, DNA, or other proteins in animals and identify diseases or predisposition stages. They are essential for the diagnosis of vector-borne diseases, respiratory pathogens, and diarrhea pathogens in companion as well as livestock animals.
Different technologies used for veterinary molecular diagnosis include conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR. A veterinary PCR test for infectious diseases is an important diagnostic tool for the veterinary virologist. It is utilized to diagnose bacterial, viral, fungal, and parasitic infections in laboratory animals.
Conventional laboratory diagnostics for veterinary pathogens primarily rely on various techniques, including neutralization, enzyme-linked Immunosorbent Assay (ELISA), complement fixation, and agar gel immunodiffusion.
However, due to advancements in technology, veterinarians around the world are increasingly using new veterinary molecular diagnostic techniques, including Western blot and Polymerase Chain Reaction (PCR), which is estimated to increase the demand for veterinary molecular diagnostics in the near future.
Although the adoption of conventional techniques remains steady, the incorporation of new molecular techniques is on the rise. Improved immunoassays, increased use of biosensors, adoption of nucleic acid diagnostics, and adoption of proteomic technologies are expected to pave the way for a bright future for the global veterinary molecular diagnostics industry.
Increase in companion animal ownership is a trend witnessed in the animal healthcare segment. Spending capacity on companion animals is also on the rise. Pet ownership in the U.S. has surged significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet according to the American Pet Products Association.
Rise in obesity among pets is projected to offer lucrative veterinary molecular diagnostics market opportunities to vendors during the forecast period. According to a report by the Association for Pet Obesity Prevention (APOP), obesity affected around 55.8% of dogs and 59.5% of cats in the U.S. in 2018.
According to the Association for Pet Obesity Prevention, 59% of dogs in the U.S. were classified as overweight or obese in 2022. Moreover, 61% of cats were classified as overweight or obese by their veterinary care provider.
Vector-borne diseases have been increasingly reported in dogs and cats worldwide. Viruses, bacteria, protozoa, helminths, and other pathogens transmit vector-borne diseases in dogs and cats. Vector-borne diseases have been emerging or re-emerging in many geographical areas, alarming new disease threats and economic losses.
According to the World Health Organization, vector-borne diseases account for more than 17% of all infectious diseases, causing more than 700,000 deaths annually.
R&D of advanced diagnostic techniques is projected to spur the veterinary molecular diagnostics market growth in the near future. Some of the recent novel and groundbreaking discoveries in diverse diagnostics and therapeutic tools about animal health are expected to open up new avenues for veterinary molecular diagnostics companies.
Considerable progress made in the detection, management, and treatment of infectious and non-infectious diseases among animals is expected to fuel the veterinary molecular diagnostics industry trajectory during the forecast period.
Innovations in the field of veterinary molecular diagnostics are primarily driven by advancements in technology, research, and increasing investments from private as well as non-private business entities.
Progress in veterinary molecular diagnostics has also provided a considerable boost to the economies and food security of several developing countries, including India and China- a factor that is expected to boost the veterinary molecular diagnostics market share in the near future.
The past and newly developed veterinary molecular diagnostic techniques play an imperative role in the detection and identification of new and emerging pathogens in livestock due to which, the adoption rates continue to move in the upward trajectory.
The advent of new vaccines and recent progress made by veterinary molecular diagnostic techniques by opting for genomic approaches are fueling the veterinary molecular diagnostics market size. Noteworthy progress made by DNA sequencing platforms and major developments in the data analysis space are also some of the key factors that are expected to provide a solid boost to the overall market development.
Several private as well as government laboratories involved in the current veterinary molecular diagnostics market landscape are increasingly focusing on improving the accuracy of their veterinary molecular diagnostics to gain a considerable advantage.
The increase in adoption of DNA sequencing platforms and the high-throughput data generated by leveraging these platforms are increasingly being analyzed by using computational genomics and bioinformatics.
According to the latest veterinary molecular diagnostics market forecast, the kits & reagents product type segment is projected to hold largest share from 2023 to 2031. Ready-to-use kits are gaining traction in the market as they are user-friendly and require fewer steps. These kits offer a streamlined workflow and help monitor a wide range of pathogens.
According to the latest veterinary molecular diagnostics market analysis, North America held largest share in 2022. Rise in number of companion animals is driving the market dynamics in the region. R&D of new products is also boosting the market statistics in North America.
In July 2023, Alveo Technologies, Inc. (Alveo), a molecular sensing and diagnostics company, launched a web-based partner portal and a suite of enablement software tools to further drive innovative partnerships onto the platform to co-develop and commercialize rapid, point-of-need diagnostic solutions across multiple life sciences sectors.
Major players are integrating Artificial Intelligence (AI) in companion animal molecular diagnostics to provide multidimensional images of sample findings.
They are also employing AI to offer consistent, accurate results within minutes. IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Zoetis, Inc., Neogen Corporation, bioMérieux SA, QIAGEN N.V., Biomedica Medizinprodukte GmbH, Bioneer, Mars, Incorporated, and Innovative Diagnostics
The veterinary molecular diagnostics market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 543.9 Mn |
| Market Forecast Value in 2031 | US$ 1.1 Bn |
| Growth Rate (CAGR) | 7.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 543.9 Mn in 2022
It is projected to grow at a CAGR of 7.9% from 2023 to 2031
Growth in pet ownership and rise in prevalence of vector-borne diseases
North America was the most lucrative region in 2022
IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Zoetis, Inc., Neogen Corporation, bioMérieux SA, QIAGEN N.V., Biomedica Medizinprodukte GmbH, Bioneer, Mars, Incorporated, and Innovative Diagnostics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Molecular Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Instruments & Software
6.3.2. Kits & Reagents
6.3.3. Services
6.4. Market Attractiveness, by Product Type
7. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. Conventional PCR
7.3.2. Singleplex PCR
7.3.3. Multiplex PCR
7.3.4. Real-time PCR
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Technology
8. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, By Disease Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Disease Type, 2017–2031
8.3.1. Vector-borne Diseases
8.3.2. Respiratory Pathogens
8.3.3. Diarrhea Pathogens
8.3.4. Others
8.4. Market Attractiveness, By Disease Type
9. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Animal Type
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Animal Type, 2017–2031
9.3.1. Companion Animal
9.3.2. Livestock Animal
9.4. Market Attractiveness, by Animal Type
10. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals/Clinics
10.3.2. Reference Laboratories
10.4. Market Attractiveness, by End-user
11. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Veterinary Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Instruments & Software
12.2.2. Kits & Reagents
12.2.3. Services
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Conventional PCR
12.4.2. Singleplex PCR
12.4.3. Multiplex PCR
12.4.4. Real-time PCR
12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, By Disease Type, 2017–2031
12.6.1. Vector-borne Diseases
12.6.2. Respiratory Pathogens
12.6.3. Diarrhea Pathogens
12.6.4. Others
12.7. Market Attractiveness, By Disease Type
12.8. Market Value Forecast, by Animal Type, 2017–2031
12.8.1. Companion Animal
12.8.2. Livestock Animal
12.9. Market Attractiveness, by Animal Type
12.10. Market Value Forecast, by User End-user, 2017–2031
12.10.1. Hospitals/Clinics
12.10.2. Reference Laboratories
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Product Type
12.13.2. By Technology
12.13.3. By Disease Type
12.13.4. By Animal Type
12.13.5. By End-user
12.13.6. By Country
13. Europe Veterinary Molecular Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Instruments & Software
13.2.2. Kits & Reagents
13.2.3. Services
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Conventional PCR
13.4.2. Singleplex PCR
13.4.3. Multiplex PCR
13.4.4. Real-time PCR
13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, By Disease Type, 2017–2031
13.6.1. Vector-borne Diseases
13.6.2. Respiratory Pathogens
13.6.3. Diarrhea Pathogens
13.6.4. Others
13.7. Market Attractiveness, By Disease Type
13.8. Market Value Forecast, by Animal Type, 2017–2031
13.8.1. Companion Animal
13.8.2. Livestock Animal
13.9. Market Attractiveness, by Animal Type
13.10. Market Value Forecast, by User End-user, 2017–2031
13.10.1. Hospitals/Clinics
13.10.2. Reference Laboratories
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Product Type
13.13.2. By Technology
13.13.3. By Disease Type
13.13.4. By Animal Type
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Instruments & Software
14.2.2. Kits & Reagents
14.2.3. Services
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Conventional PCR
14.4.2. Singleplex PCR
14.4.3. Multiplex PCR
14.4.4. Real-time PCR
14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, By Disease Type, 2017–2031
14.6.1. Vector-borne Diseases
14.6.2. Respiratory Pathogens
14.6.3. Diarrhea Pathogens
14.6.4. Others
14.7. Market Attractiveness, By Disease Type
14.8. Market Value Forecast, by Animal Type, 2017–2031
14.8.1. Companion Animal
14.8.2. Livestock Animal
14.9. Market Attractiveness, by Animal Type
14.10. Market Value Forecast, by User End-user, 2017–2031
14.10.1. Hospitals/Clinics
14.10.2. Reference Laboratories
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Product Type
14.13.2. By Technology
14.13.3. By Disease Type
14.13.4. By Animal Type
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Veterinary Molecular Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Instruments & Software
15.2.2. Kits & Reagents
15.2.3. Services
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. Conventional PCR
15.4.2. Singleplex PCR
15.4.3. Multiplex PCR
15.4.4. Real-time PCR
15.4.5. Others
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, By Disease Type, 2017–2031
15.6.1. Vector-borne Diseases
15.6.2. Respiratory Pathogens
15.6.3. Diarrhea Pathogens
15.6.4. Others
15.7. Market Attractiveness, By Disease Type
15.8. Market Value Forecast, by Animal Type, 2017–2031
15.8.1. Companion Animal
15.8.2. Livestock Animal
15.9. Market Attractiveness, by Animal Type
15.10. Market Value Forecast, by User End-user, 2017–2031
15.10.1. Hospitals/Clinics
15.10.2. Reference Laboratories
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Product Type
15.13.2. By Technology
15.13.3. By Disease Type
15.13.4. By Animal Type
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product Type, 2017–2031
16.2.1. Instruments & Software
16.2.2. Kits & Reagents
16.2.3. Services
16.3. Market Attractiveness, by Product Type
16.4. Market Value Forecast, by Technology, 2017–2031
16.4.1. Conventional PCR
16.4.2. Singleplex PCR
16.4.3. Multiplex PCR
16.4.4. Real-time PCR
16.4.5. Others
16.5. Market Attractiveness, by Technology
16.6. Market Value Forecast, By Disease Type, 2017–2031
16.6.1. Vector-borne Diseases
16.6.2. Respiratory Pathogens
16.6.3. Diarrhea Pathogens
16.6.4. Others
16.7. Market Attractiveness, By Disease Type
16.8. Market Value Forecast, by Animal Type, 2017–2031
16.8.1. Companion Animal
16.8.2. Livestock Animal
16.9. Market Attractiveness, by Animal Type
16.10. Market Value Forecast, by User End-user, 2017–2031
16.10.1. Hospitals/Clinics
16.10.2. Reference Laboratories
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Product Type
16.13.2. By Technology
16.13.3. By Disease Type
16.13.4. By Animal Type
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. IDEXX Laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Thermo Fisher Scientific, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Zoetis, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Neogen Corporation
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. bioMérieux SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. QIAGEN N.V.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Biomedica Medizinprodukte GmbH
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Bioneer
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Mars, Incorporated
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Innovative Diagnostics
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
List of Tables
Table 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 03: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 04: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 05: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 10: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 11: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 12: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 16: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 17: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 18: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 21: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 28: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 29: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 30: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 33: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 34: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031
Table 35: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2022
Figure 04: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Technology, 2022
Figure 05: Global Veterinary Molecular Diagnostics Market Value Share, by Technology, 2022
Figure 06: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), By Disease Type, 2022
Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, By Disease Type, 2022
Figure 08: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
Figure 09: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
Figure 10: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 11: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
Figure 12: Global Veterinary Molecular Diagnostics Market Value Share, by Region, 2022
Figure 13: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
Figure 14: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 15: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 16: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 18: Global Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 19: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
Figure 20: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
Figure 21: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
Figure 22: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 23: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
Figure 24: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2022–2031
Figure 25: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
Figure 26: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023–2031
Figure 28: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country, 2022–2031
Figure 29: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 30: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 31: North America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 32: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031
Figure 33: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031
Figure 34: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 35: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 36: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031
Figure 37: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031
Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 39: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 40: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 43: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 44: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 45: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031
Figure 46: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031
Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031
Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031
Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 53: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 55: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 56: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 57: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 58: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031
Figure 59: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031
Figure 60: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 61: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031
Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031
Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 65: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 66: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 67: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 68: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 69: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 70: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 71: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031
Figure 72: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031
Figure 73: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 74: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 75: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031
Figure 76: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031
Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 78: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 79: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 80: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 81: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031
Figure 82: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031
Figure 83: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031
Figure 84: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031
Figure 85: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031
Figure 86: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 87: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031
Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031
Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031
Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Veterinary Molecular Diagnostics Market
